National Research Corporation (NRC)
- Previous Close
18.75 - Open
18.75 - Bid 18.44 x 100
- Ask 19.08 x 100
- Day's Range
18.62 - 18.79 - 52 Week Range
17.62 - 42.19 - Volume
3,670 - Avg. Volume
73,967 - Market Cap (intraday)
437.123M - Beta (5Y Monthly) 0.53
- PE Ratio (TTM)
16.62 - EPS (TTM)
1.12 - Earnings Date Oct 25, 2024
- Forward Dividend & Yield 0.48 (2.56%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
--
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
www.nrchealth.com435
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NRC
View MorePerformance Overview: NRC
Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NRC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NRC
View MoreValuation Measures
Market Cap
440.18M
Enterprise Value
490.35M
Trailing P/E
16.74
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.13
Price/Book (mrq)
12.71
Enterprise Value/Revenue
3.40
Enterprise Value/EBITDA
11.31
Financial Highlights
Profitability and Income Statement
Profit Margin
18.79%
Return on Assets (ttm)
18.53%
Return on Equity (ttm)
58.56%
Revenue (ttm)
144.16M
Net Income Avi to Common (ttm)
27.08M
Diluted EPS (ttm)
1.12
Balance Sheet and Cash Flow
Total Cash (mrq)
3.46M
Total Debt/Equity (mrq)
156.84%
Levered Free Cash Flow (ttm)
21.74M
Research Analysis: NRC
View MoreCompany Insights: NRC
NRC does not have Company Insights